TAMMIE COPP: Open Payments
NPI 1104427871 · CORNING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 28 payments from 8 companies in 2025. Trend: 2023 $1,099 · 2024 $725 · 2025 $903
Food & beverage: $804Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $268 |
| GlaxoSmithKline, LLC. | 14 | $228 |
| AstraZeneca Pharmaceuticals LP | 3 | $179 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Lilly USA, LLC | 3 | $45 |
| HARMONY BIOSCIENCES LLC | 2 | $40 |
| Fisher & Paykel Healthcare Inc | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: DUPIXENT, AIRSUPRA, AREXVY, TRELEGY ELLIPTA, NUCALA, TEZSPIRE, ZEPBOUND, WAKIX.
Industry payments across NY — which companies pay providers there.
